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Abstract
Background: Hyperlipidemia and high fasting plasma glucose levels at the first prenatal visit (First Visit FPG) are
both related to gestational diabetes mellitus, maternal obesity/overweight and fetal overgrowth. The purpose of the
present study is to investigate the correlation between First Visit FPG and lipid concentrations, and their potential
association with offspring size at delivery.
Materials and methods: Pregnant women that received regular prenatal care and delivered in our center in 2013
were recruited for the study. Fasting plasma glucose levels were tested at the first prenatal visit (First Visit FPG) and
prior to delivery (Before Delivery FPG). HbA1c and lipid profiles were examined at the time of OGTT test. Maternal
and neonatal clinical data were collected for analysis. Data was analyzed by independent sample t test, Pearson
correlation, and Chi-square test, followed by partial correlation and multiple linear regression analyses to confirm
association. Statistical significance level was α =0.05.
Results: Analyses were based on 1546 mother-baby pairs. First Visit FPG was not correlated with any lipid parameters
after adjusting for maternal pregravid BMI, maternal age and gestational age at First Visit FPG. HbA1c was positively
correlated with triglyceride and Apolipoprotein B in the whole cohort and in the NGT group after adjusting for maternal
age and maternal BMI at OGTT test. Multiple linear regression analyses showed neonatal birth weight, head circumference
and shoulder circumference were all associated with First Visit FPG and triglyceride levels.
Conclusion: Fasting plasma glucose at first prenatal visit is not associated with lipid concentrations in mid-pregnancy,
but may influence fetal growth together with triglyceride concentration.
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Background
The intrauterine metabolic environment is of great import-
ance for the development of offspring [1]. Gestational dia-
betes mellitus (GDM) is a common metabolic complication
that may result in an adverse intrauterine environment and
lead to fetal overgrowth [2–4], as well as short- and long-
term complications for the offspring [5–8].
Hyperlipidemia, a disorder that may occur in GDM
mothers [9] also contributes to the adverse intrauterine
environment [10], and often occurs along with hypergly-
cemia [11]. Early detection of hyperlipidemia in GDM
patients is of great importance. A previous study found
that fasting plasma glucose (FPG) at the first prenatal
visit is related to glycemic metabolism in the mid-
gestational period (24-28 weeks) [12]. However, whether
FPG at the first prenatal visit is associated with mid-
gestational lipid metabolism has not been reported.
Recently, we reported that maternal pre-gravid BMI
may influence FPG levels, and FPG at the first prenatal
visit is associated with fetal growth [13]. Since maternal
obesity/overweight is often complicated with hyperlipid-
emia [14], and hyperlipidemia may cause of fetal
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overgrowth [10], we are interested in studying any pos-
sible relationship between maternal FPG, lipid metabol-
ism and fetal growth.
In this respect, the primary purpose of the present
study is to investigate the relationship between FPG at
the first prenatal visit and lipid concentration in the
mid-gestational stage. We also aim to examine the asso-




Singleton pregnant women who underwent a FPG test at
the first prenatal visit (between 10 and 24 gestational
weeks), received regular prenatal care (including a lipid
concentration test at the time of OGTT test), and deliv-
ered in our center from January to December 2013 were
recruited for the present study.
The diagnosis of GDM is based on a 75-g Oral
Glucose Tolerance Test (OGTT) performed at 24-28
gestational weeks, according to the ADA criteria (fast-
ing ≥ 5.1 mmol/L, 1 h ≥ 10.0 mmol/L, 2 h ≥ 8.5 mmol/L).
Pregnant women with overt DM before pregnancy or
treated with insulin during gestation were excluded in
the present study. All pregnant women complicated with
GDM were treated with diet.
The study has been approved by the ethical commit-
tees of the The First Affiliated Hospital of Sun Yat-sen
University [Application ID: (2014)093] , and all partici-
pants provided written informed consent.
Clinical data collection
At the first prenatal visit, maternal age, parity, the first
day of the woman’s last menstrual period (LMP) and
weight before pregnancy were self-reported, and mater-
nal height was measured with a fixed stadiometer. Ma-
ternal weights at the first prenatal visit, at the time of
OGTT test, and just prior to delivery were measured
with a calibrated digital scale and recorded for analysis.
Gestational age was calculated from the first day of the
woman’s last menstrual period (LMP) and further con-
firmed by early obstetric ultrasound. If the gestational
age calculated from the LMP was different from that cal-
culated by the early ultrasound, the gestational age from
the early ultrasound was used [15]. In the case of in vitro
fertilization, the gestational age was calculated using oo-
cyte retrieval or co-incubation date and adding 14 days
[16].
Measured neonatal parameters included birth weight,
birth length, head circumference, shoulder circumfer-
ence, and birthing method (vaginal vs. cesarean). Imme-
diately following birth, the birth weight was measured
with a calibrated electronic scale, birth length was
measured with an infantometer, and head and shoulder
circumferences were measured with a nylon tape.
Laboratory measurements
Fasting plasma glucose levels were measured using ven-
ous plasma obtained after at least 8 hours of fasting dur-
ing the first prenatal visit and the morning following
administration for delivery. A 75-g Oral Glucose Toler-
ance Test (OGTT) was performed between 24 and 28
gestational weeks. At the same time, maternal blood
samples were also obtained for the examination of
HbA1c and lipid profiles including triglyceride, choles-
terol, low density lipoprotein, high density lipoprotein,
apolipoprotein A1, apolipoprotein B, apolipoprotein E,
and lipoprotein-a.
Plasma glucose levels were measured using a GOD-
PAP kit (Human, Wiesbaden, Germany). Cholesterol
and triglyceride (TG) levels were measured using an
enzymatic colorimetric test kit (Human, Wiesbaden,
Germany). High-density lipoprotein (HDL) and low-
density lipoprotein (LDL) levels were determined by
homogeneous assay using liquicolor kits (Human, Wies-
baden, Germany). Apolipoprotein A1 and Apolipopro-
tein B were measured with standard enzymatic assay
using ApoA and ApoB kits (Human, Beckman, USA).
Apolipoprotein E was examined by an immunoturbidi-
metry assay using APO E AUTO kit (Human, Sekisui,
Japan). Lipoprotein-a was examined by a particle-
enhanced turbidimetric immunoassay (PETIA) kit (Hu-
man, Diagnostic Systems, China). HbA1c was measured
by high-performance liquid chromatography (HPLC)
using a VARIANT II TURBO HbA1c Kit (Human, Bio-
Rad, CA, USA).
Statistical analysis
Data was analyzed using SPSS Version 17.0. Continuous
and normal distributed variables were described as
mean ± SD and analyzed by independent sample t test or
Pearson correlation. Categorical variables were described
as proportions and examined by Chi-square test. Partial
correlations were applied to describe the relationship be-
tween maternal glucose and lipid parameters in the
whole cohort, GDM and NGT groups. The false discov-
ery rate was controlled by the Benjamini and Hochberg
Method [17]. Multiple linear regression analyses were
conducted to study the association between maternal
glucose/lipid parameters and neonatal birth size. A p-value
of 0.05 or less was considered significant.
Results
Baseline characteristics of the study population
1546 pregnant women were recruited for this study and
in this cohort, eighteen pregnant women were obese
(pregravid BMI > =30 kg/m2), 174 were overweight
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(pregravid BMI:25-29.9 kg/m2), 1261 were in normal
range BMI (pregravid BMI:18.5-24.9 kg/m2) and 90 were
lean (pregravid BMI < 18.5 kg/m2). Of these women, 276
developed gestational diabetes mellitus (GDM) and 1270
were of normal glucose tolerance (NGT) during preg-
nancy. Pregnant women in the GDM group were older,
contained more nullipara, had higher BMI prior to preg-
nancy, at the first prenatal visit and at the time of OGTT
test compared to the NGT group, but pre-partum BMI
between the groups were similar (Table 1).
Neonates of GDM mothers were born at an earlier
gestational age and had a shorter birth length compared
to neonates from NGT mothers. Gender of neonates,
birth weight, head circumference, shoulder circumference,
and route of birthing were similar between groups
(Table 1). Similar maternal pre-partum BMI and neonatal
birth weight between GDM and NGT groups may be a re-
sult of diet therapy for GDM pregnant women.
With respect to glucose metabolism, the GDM
group had a higher fasting glucose concentration com-
pared to the NGT group at the first prenatal visit (First
Visit FPG), at OGTT test (OGTT FPG), and prior to
delivery (the morning or next morning of administra-
tion for delivery, Before Delivery FPG). The GDM
group also had higher HbA1c levels than the NGT
group at the time of the OGTT test. Regarding lipid
metabolism, triglyceride and Apolipoprotein E levels
were higher in the GDM group, but no difference was
observed when comparing other lipid parameters be-
tween the groups (Table 1).
Correlation between maternal glycemia and lipid profile
The relationship between glycemia and lipid profile was
first analyzed using a univariate correlation followed by
a partial correlation taking related confounders into con-
sideration. Analyses were completed in the whole cohort
as well as the individual GDM and NGT groups.
The partial correlation between FPG concentration at
first prenatal visit and lipid profile was adjusted for ma-
ternal pregravid BMI, maternal age and gestational age
at First Visit FPG. As shown in Table 2, First Visit FPG
was not correlated with any lipid parameters in the
whole cohort, or in the NGT/GDM groups.
HbA1c was positively correlated with triglyceride
levels in the whole cohort (Fig. 1a, partial correlation co-
efficient r’ = 0.072, adjusted P = 0.032) and in the NGT
group (partial correlation coefficient r’ = 0.076, adjusted
P = 0.032) after adjusting for maternal age and maternal
BMI at OGTT test. HbA1c was also correlated with
Apolipoprotein B levels in the whole cohort (Fig. 1b,
partial correlation coefficient r’ = 0.071, P = 0.032) and in
the NGT group (partial correlation coefficient r’ = 0.085,
P = 0.032). HbA1c was not correlated with any lipid pa-
rameters in the GDM group.
Maternal glucose levels and lipid metabolism impact fetal
growth
Fetal growth is influenced by maternal energy metabolic
status, and FPG at first prenatal visit is associated with
neonatal birth weight. Therefore, we further studied the
Table 1 Baseline characteristics of the research population
GDM NGT P
Number 276 1270





Before pregnancy 21.20±3.00 20.47±2.60 <0.001
At first prenatal visit 22.60±3.26 21.63±2.80 <0.001
At OGTT test 24.46±3.09 23.65±2.65 <0.001
At delivery 25.76±3.16 26.04±2.87 0.195
Fasting plasma glucose
(mmol/L)
First Visit FPG 4.46±0.51 4.27±0.38 <0.001
OGTT FPG 4.61±0.53 4.27±0.31 <0.001
Before Delivery FPG 5.22±1.29 4.90±0.99 <0.001
HbA1c (%) 5.04±0.42 4.82±0.31 <0.001
HbA1c (mmol/mol) 31.83±4.63 29.37±3.42 <0.001
Lipid profile
Triglyceride (mmol/L) 2.31±0.84 2.09±0.76 <0.001







Apolipoprotein A1 (g/L) 2.05±0.31 2.01±0.34 0.103
Apolipoprotein B (g/L) 0.94±0.17 0.94±0.18 0.820






Neonatal gender (%) 0.947
Male 143(51.8) 969(76.2)
Female 133(48.1) 301(23.7)
Gestational age (day) 271.33±11.70 273.94±11.91 <0.001





Birth length (cm) 48.96±2.63 49.33±2.39 0.022
head circumference (cm) 33.27±1.98 33.35±1.73 0.583
shoulder circumference (cm) 34.33±2.52 34.45±2.32 0.482
Birth method (%) 0.549
Vaginal 121(43.8) 584(45.9)
Cesarean 155(56.1) 686(54)
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impact of both maternal glucose and lipid concentration
on fetal growth.
We conducted univariate correlations between neo-
natal birth weight, length, head circumference, shoulder
circumference, and maternal glucose and lipid concen-
trations followed by partial correlations taking gesta-
tional age and pregravid BMI as confounders. In the
whole cohort, neonatal birth weight, head circumference
and shoulder circumference were all positively correlated
with First Visit FPG, OGTT FPG, triglyceride and Apoli-
poprotein E, but not with other glucose or lipid parame-
ters (Table 3). Birth length was not correlated with any
glucose or lipid parameters in this research cohort.
Next, we conducted a multiple linear regression ana-
lysis to investigate the association between maternal
clinical characteristics (BMI, GDM), glucose/lipid pa-
rameters and neonatal birth size (birth weight, head cir-
cumference and shoulder circumference). The regression
analysis showed that neonatal birth weight, head circum-
ference and shoulder circumference were all best de-
scribed by models that included First Visit FPG,
triglyceride, maternal pregravid BMI and gestational age
(Table 4).
Discussion
Fasting plasma glucose (FPG) at the first prenatal visit is
related to the diagnosis of GDM [12], maternal pre-
gravid BMI and neonatal birth weight [13]. Since hyper-
lipidemia is an important link between GDM [9],
maternal obesity/overweight [18] and fetal overgrowth
[10], we explored the relationship between First Visit
FPG and lipid concentrations, and their potential influ-
ence on fetal growth. The result of the present study
Table 2 Partial Correlation between fasting plasma glucose,
HbA1c and lipid profile
First Visit FPG HbA1c
R' P R' P
Whole research population
Triglyceride 0.045 0.275 0.072 0.032*
Cholesterol 0.046 0.275 0.003 0.919
Low density lipoprotein 0.042 0.275 0.012 0.757
High density lipoprotein -0.010 0.712 -0.026 0.757
Apolipoprotein A1 -0.010 0.712 0.013 0.757
Apolipoprotein B 0.034 0.299 0.071 0.032*
Apolipoprotein E 0.037 0.299 -0.013 0.757
Lipoprotein-a -0.014 0.712 -0.015 0.757
GDM group
Triglyceride 0.020 0.946 0.028 0.898
Cholesterol -0.004 0.946 -0.028 0.898
Low density lipoprotein 0.023 0.946 -0.038 0.898
High density lipoprotein -0.076 0.592 0.022 0.898
Apolipoprotein A1 -0.078 0.592 -0.008 0.898
Apolipoprotein B 0.046 0.916 0.033 0.898
Apolipoprotein E 0.006 0.946 -0.048 0.898
Lipoprotein-a -0.110 0.592 -0.015 0.898
NGT group
Triglyceride 0.042 0.29 0.076 0.036*
Cholesterol 0.062 0.232 0.016 0.886
Low density lipoprotein 0.049 0.290 0.032 0.558
High density lipoprotein 0.014 0.706 -0.039 0.485
Apolipoprotein A1 0.004 0.884 0.008 0.886
Apolipoprotein B 0.029 0.496 0.085 0.032*
Apolipoprotein E 0.043 0.290 -0.004 0.886
Lipoprotein-a 0.019 0.684 -0.010 0.886
Partial correlations between First Visit FPG and lipid profiles were adjusted for
maternal age, pre-gravid BMI and the gestational age at the First Visit FPG.
Partial correlations between HbA1c and lipid profiles were adjusted for maternal
age, maternal BMI at the time of the OGTT test. All P values were corrected using
the BH method (1995)
Fig. 1 Relationship between HbA1c and lipid concentrations at the
time of OGTT test. a) Correlation between HbA1c and triglyceride
concentration at the time of OGTT test; b) Correlation between
HbA1c and apolipoprotein B concentration at the time of OGTT test
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showed that, although First Visit FPG was not correlated
with any lipid parameters at mid-gestation, it was associ-
ated with neonatal birth weight, head circumference and
shoulder circumference together with maternal triglycer-
ide levels.
The crosstalk between glucose and lipid metabolism is
well established [19]. During pregnancy, hyperglycemia
is typically accompanied by hyperlipidemia [20] and to-
gether they promote an adverse metabolic intrauterine
environment and lead to macrosomia [6]. FPG levels at
the first prenatal visit is strongly correlated with glucose
tolerance in mid pregnancy [12], but whether FPG levels
can influence lipid metabolism is unknown.
In the present study, First Visit FPG was not corre-
lated with any of the measured lipid parameters in mid-
gestation. However, HbA1c concentration correlated
with triglyceride and Apolipoprotein B levels in the
NGT group. Since HbA1c concentration represents the
average glucose level 2-3 months before testing [21],
mid-pregnancy triglyceride and Apolipoprotein B levels
would be related to earlier stage glucose metabolism.
However, a single test of FPG at the first prenatal visit
was not able to predict hyperlipidemia at the mid-
gestational stage.
Fetal growth is influenced by maternal glucose levels
[22] and lipid metabolism [23], so in the present study,
we analyzed glucose and lipid factors on neonatal
growth parameters. We found that maternal First Visit
FPG and triglyceride levels were correlated with neo-
natal birth weight, head circumference and shoulder
Table 3 Partial Correlation between maternal glycemic/lipid metabolism and neonatal birth weight, length, head circumference and
shoulder circumference
Birth weight Birth length head circumference shoulder circumference
R' P R' P R' P R' P
Glucose metabolism
First Visit FPG 0.098 <0.001 0.047 0.086 0.071 0.010 0.084 0.002
OGTT FPG 0.094 0.001 0.033 0.232 0.055 0.048 0.091 0.001
OGTT 1hr 0.029 0.287 -0.040 0.148 0.052 0.061 0.052 0.058
OGTT 2hr 0.027 0.327 0.012 0.677 0.035 0.202 0.049 0.075
Before Delivery FPG 0.011 0.702 -0.022 0.430 -0.017 0.549 0.020 0.480
HbA1c -0.013 0.647 -0.026 0.350 -0.024 0.382 -0.019 0.495
Lipid metabolism
Triglyceride 0.100 <0.001 -0.003 0.909 0.094 0.001 0.120 <0.001
Cholesterol 0.018 0.518 -0.010 0.710 0.006 0.815 0.024 0.378
Low density lipoprotein -0.005 0.843 -0.018 0.526 -0.015 0.578 -0.001 0.979
High density lipoprotein -0.011 0.701 0.022 0.433 -0.049 0.074 -0.039 0.159
Apolipoprotein A1 -0.008 0.760 -0.002 0.945 -0.015 0.576 -0.019 0.484
Apolipoprotein B -0.016 0.564 -0.032 0.252 0.008 0.773 0.028 0.314
Apolipoprotein E 0.062 0.025 -0.007 0.813 0.064 0.020 0.077 0.006
Lipoprotein-a -0.033 0.235 -0.031 0.262 -0.042 0.129 -0.026 0.342
All partial correlations were adjusted for gestational age and pregravid BMI
Table 4 The association between maternal glucose/ lipid parameters and neonatal birth size
Birth weight Head circumference Shoulder circumference
Effect Estimate beta
coefficient
SE P Estimate beta
coefficient
SE P Estimate beta
coefficient
SE P
First Visit FPG 0.073 24.363 0.001 0.080 0.056 0.001 0.090 0.072 <0.001
OGTT FPG NS NS NS
Triglyceride 0.070 13.238 0.001 0.049 0.102 0.040 0.065 0.131 0.005
Apolipoprotein E NS NS NS
Pregravid BMI 0.146 3.846 <0.001 0.108 0.016 <0.001 0.132 0.021 <0.001
GDM NS NS NS
Gestational Age 0.588 0.870 <0.001 0.426 0.004 <0.001 0.481 0.005 <0.001
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circumference, after adjusting for gestational age and
GDM. Other lipid parameters, HbA1c and after meal
glucose (OGTT 1 and 2 hour) were not associated with
any neonatal birth size characteristics. This result sug-
gests that maternal fasting glucose and triglyceride con-
centrations play an important role in fetal growth.
The association between maternal triglyceride and
neonatal birth weight has been reported in previous
studies [24, 25], and our results support these studies in
a much larger study population. Neonatal head circum-
ference has been shown to be negatively correlated with
low-density lipoprotein in cord plasma [26]; however, to
the best of our knowledge, the positive association be-
tween maternal triglyceride and neonatal head and
shoulder circumference is first described in the present
study. Our recently published article found that First
Visit FPG was associated with neonatal birth weight
[13], and the present study revealed the association be-
tween First Visit FPG levels and neonatal head and
shoulder circumference in a new research population.
There are several limitations in the present study. First
of all, variation of lipid concentration is considerable
during gestation [27], but we only obtained the lipid
values at the time of the OGTT test. Additionally, since
the BMI of most participants in the present cohort were
within the normal range, the result of the present study
would be applicable mainly in pregnant women with
normal BMI. Further, although the present study has
provided insight into the association between glucose,
lipid factors and neonatal birth size, the retrospective
design could be seen as another limitation. Therefore,
further prospective studies measuring lipid concentra-
tions across multiple gestational times in a wide ranging
population is needed to increase validation of the result.
Conclusion
In summary, mid-pregnancy triglyceride levels are corre-
lated with earlier stage glucose metabolism, but a single
FPG test is not sufficient to predict triglyceride concen-
trations in the mid-gestational period. In addition, neo-
natal birth weight, head circumference, and shoulder
circumference were all associated with maternal fasting
glucose levels at the first prenatal visit and triglyceride
levels at mid-gestation, but not with after-meal glucose
levels at the time of OGTT test or with other lipid
parameters.
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